Sökning: WFRF:(Pasquini Marcelo) > HLA-matched sibling...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04079naa a2200697 4500 | |
001 | oai:gup.ub.gu.se/82183 | |
003 | SwePub | |
008 | 240528s2008 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/821832 URI |
024 | 7 | a https://doi.org/10.1016/j.bbmt.2008.06.0202 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Pasquini, Ricardo4 aut |
245 | 1 0 | a HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. |
264 | 1 | b Elsevier BV,c 2008 |
520 | a Related to the underlying DNA repair defect that is the hallmark of Fanconi anemia (FA), preparatory regimen-related toxicities have been obstacles to hematopoietic cell transplantation (HCT). In an attempt to decrease the risk and severity of regimen-related toxicities, nonirradiation regimens have been explored. The aim of this study is to compare outcomes after irradiation and nonirradiation regimens in 148 FA patients and identify risk factors impacting upon HCT outcomes. Hematopoietic recovery, acute and chronic graft-versus-host disease (aGVHD, GVHD), and mortality were similar after irradiation and nonirradiation regimens. In both groups of recipients aged >10 years, prior use of androgens and cytomegalovirus seropositivity in either the donor or recipient were associated with higher mortality. With median follow-ups >5 years, the 5-year probability of overall survival, adjusted for factors impacting overall mortality was 78% and 81% after irradiation and nonirradiation regimens, P = .61. In view of the high risk of cancer and other radiation-related effects on growth and development, these results support the use of nonirradiation preparatory regimens. As the peak time for developing solid tumors after HCT is 8 to 9 years, longer follow-up is required before definitive statements can be made regarding the impact of nonirradiation regimens on cancer risk. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Pediatrik0 (SwePub)302212 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Pediatrics0 (SwePub)302212 hsv//eng |
653 | a Adolescent | |
653 | a Adult | |
653 | a Fanconi Anemia | |
653 | a therapy | |
653 | a Female | |
653 | a Graft vs Host Disease | |
653 | a Hematopoiesis | |
653 | a Hematopoietic Stem Cell Transplantation | |
653 | a methods | |
653 | a mortality | |
653 | a Histocompatibility Testing | |
653 | a Humans | |
653 | a Male | |
653 | a Radiotherapy | |
653 | a Registries | |
653 | a Retrospective Studies | |
653 | a Risk Factors | |
653 | a Siblings | |
653 | a Survival Analysis | |
653 | a Transplantation Conditioning | |
653 | a methods | |
653 | a standards | |
653 | a Treatment Outcome | |
700 | 1 | a Carreras, Jeanette4 aut |
700 | 1 | a Pasquini, Marcelo C4 aut |
700 | 1 | a Camitta, Bruce M4 aut |
700 | 1 | a Fasth, Anders,d 1945u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences4 aut0 (Swepub:gu)xfasan |
700 | 1 | a Hale, Gregory A4 aut |
700 | 1 | a Harris, Richard E4 aut |
700 | 1 | a Marsh, Judith C4 aut |
700 | 1 | a Robinson, Anibal J4 aut |
700 | 1 | a Zhang, Mei-Jie4 aut |
700 | 1 | a Eapen, Mary4 aut |
700 | 1 | a Wagner, John E4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper4 org |
773 | 0 | t Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantationd : Elsevier BVg 14:10, s. 1141-7q 14:10<1141-7x 1523-6536 |
773 | 0 | t Biology of Blood and Marrow Transplantationd : Elsevier BVg 14:10, s. 1141-7q 14:10<1141-7x 1083-8791 |
856 | 4 | u https://doi.org/10.1016/j.bbmt.2008.06.020 |
856 | 4 8 | u https://gup.ub.gu.se/publication/82183 |
856 | 4 8 | u https://doi.org/10.1016/j.bbmt.2008.06.020 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.